3,4-dihydro-2H-1,5-benzodioxepine-7-carbaldehyde, 95.0%, 1g

4-Iodo-2-(trifluoromethyl)benzonitrile>98.0%(GC)1g

(S)-Dimethyl 2-acetamidosuccinate, 95.0%, 100mg

(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-yl (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoate, 98%, 100mg

2,4,6-Tribromo-3-hydroxybenzaldehyde>98.0%(GC)25g

Dansylsarcosine Cyclohexylammonium Salt [for Albumin binding assay]>98.0%(T)100mg

(6-Cyano-2-methylpyridin-3-yl)boronic acid, 98%, 250mg

4-Phenyltetrahydro-2H-pyran-4-carbaldehyde, 95+%, 250mg

Thalidomide-NH-C6-NH2 (TFA), 100mg

2-(1,3-Benzothiazol-2-yl)propan-2-ol, 97%, 100mg

5,6-Dihydro-4H-benzo[b]thieno[2,3-d]azepine-2-carboxylic acid, 95.0%, 100mg

3,4-Difluorobenzene-1,2-diamine, 98.0%, 100g

3-Fluorophenol, 99.0%, 10g